CME webinar: Hepatitis C, B, and HIV: Screening and Management
Mar. 2024Education/Webinars
Please join us for a live, continuing medical education (CME)-accredited webinar on Wednesday, May 1, from noon to 1 p.m. The webinar will provide an overview of hepatitis C, B, and HIV screening and management. During this presentation, our expert will:
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
- Review the prevalence, trends, and screening recommendations for hepatitis B, C, and HIV.
- Discuss recommended screening tests and the interpretation of the results.
- Review the management of hepatitis C and the role of primary care in its treatment.
- Discuss considerations with hepatitis C, B, and HIV coinfections.
Presenter:
Nicholas DeGregorio, MD, MMM, FACP,
Associate Vice President, Medicaid Medical Services, UPMC Health Plan
Register now.
This webinar will be recorded.
This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
This activity has been designated as and meets the Pennsylvania licensure requirement for Patient Safety-Risk Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes.
Provider is responsible for verifying CME eligibility.
Recent Announcements
Medical device correction: FreeStyle Libre 3 (Abbott – December)
Abbott has announced a medical device correction for certain FreeStyle Libre 3 sensors. These sensors monitor blood glucose levels as part of the FreeStyle Libre system, which includes a sensor, reader, and app. The correction applies only to the sensor. No other Libre products or Abbott biowearables are affected.Dec. 2025Pharmacy Updates
CME Webinar: The State of Telehealth in 2026
Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.Dec. 2025Education/Webinars
Formulary updates effective Jan. 1, 2026
Review upcoming policy and operational updatesDec. 2025Pharmacy Updates